Active Not RecruitingNCT03788811
Retinal signals for identifying schizophrenia and bipolarity I
About this title
ERG Components in Schizophrenia and Bipolar Disorder Type I
Read the official source — NCT03788811Observational studyAges 18–50Multiple countries
Understand this study
Who could participate?
Listed age limits: 18 years to 50 years.
- Listed locations
- Garden Grove and 18 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 5, 2018
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 300
- Sponsor
- diaMentis Inc.
- Sponsor type
- Other organization
- Study type
- Observational
- Intervention type
- Device
- Locations
- United States, Australia, Canada
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT03788811
- Official title
Show the full official title
Assessment of ERG Components to Discriminate Between Schizophrenia and Bipolar Disorder Type I
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Garden Grove, United States · Lemon Grove, United States · Torrance, United States
15 more locations
- Lauderhill, United States
- Miami Lakes, United States
- Belmont, United States
- Piscataway, United States
- Glen Oaks, United States
- Rochester, United States
- Staten Island, United States
- Irving, United States
- Clayton, Australia
- Geelong, Australia
- Melbourne, Australia
- Kingston, Canada
- Toronto, Canada
- Montreal, Canada
- Saint-Georges, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is diaMentis Inc.
Who can participate?
Listed age limits: 18 years to 50 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
